From the Project on Government Oversight (http://www.pogo.org/):
President Donald Trump called the FDA drug approval process slow and burdensome, but the evidence he cited could point to the opposite conclusion. Slashing regulatory restraints as he proposed could pose medical and financial hazards.
Read more at http://www.pogo.org/blog/2017/03/trump-dangerous-prescription-FDA.html.
Leave a Reply